In utero exposure and endometriosis

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 27, Issue 3, 2014, Pages 303-308

  Benagiano, Giuseppe ^a   Brosens, Ivo ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b LEUVEN INSTITUTE FOR FERTILITY AND EMBRYOLOGY   (Belgium)

Author keywords

Endocrine disrupting chemicals; Endometriosis; Environmental toxins; Reproduction

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ALCOHOL; CAFFEINE; DIESEL FUEL; DIETHYLSTILBESTROL; DIOXIN; DNA; ENDOCRINE DISRUPTOR; LEAD; MATRIX METALLOPROTEINASE; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B; THALIDOMIDE; TOXIN; VITAMIN;

ADENOMYOSIS; ALCOHOL CONSUMPTION; BODY HEIGHT; BODY MASS; BREAST FEEDING; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL COMMUNICATION; CHROMATIN; CLEAR CELL CARCINOMA; CONGENITAL MALFORMATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DNA MODIFICATION; DOWN REGULATION; ENDOMETRIOSIS; ENVIRONMENTAL FACTOR; EPIGENETICS; EXHAUST GAS; FEMALE INFERTILITY; FETUS DEVELOPMENT; FETUS GROWTH; FETUS MORTALITY; FETUS RISK; GENE EXPRESSION; GENOME; GENOTYPE ENVIRONMENT INTERACTION; HORMONE SYNTHESIS; HUMAN; HYPERPLASIA; IMMUNE RESPONSE; INFLAMMATION; INGUINAL HERNIA; LAPAROSCOPY; LAPAROTOMY; LEIOMYOMA; LOW BIRTH WEIGHT; MATERNAL NUTRITION; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PLACENTAL TRANSFER; POLYP; PREGNANCY; PREMATURE LABOR; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SAFETY; SMOKING; SPONTANEOUS ABORTION; UTERINE CERVIX CARCINOMA; UTERINE CERVIX DISEASE; UTERINE CERVIX STENOSIS; UTERUS; UTERUS MALFORMATION; VAGINA CARCINOMA;

BENZHYDRYL COMPOUNDS; DIETHYLSTILBESTROL; DIOXINS; ENDOMETRIOSIS; ENVIRONMENTAL POLLUTANTS; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; PHENOLS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PRENATAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; RISK FACTORS;

EID: 84891930526     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.814630     Document Type: Review

References (60)

1. Forsdahl A. Are poor living conditions in childhood and adolescence an important risk factor for arteriosclerotic heart disease? Br J Prev Soc Med 1977;31:91-5.
2. Barker DJP. The fetal and infant origins of adult disease. Br Med J 1990;301:1111.
3. Barker DJP, Osmond C. Infant mortality, childhood nutrition and ischaemic heart disease in England and Wales. Lancet 1986;i: 1077-81.
4. Barker DJP, Osmond C. Death rates from stroke in England and Wales predicted from past maternal mortality. Brit Med J 1986;295: 83-6.
5. Barker DJP. Mothers, babies and health in later life. Churchill Livingstone, Edinburgh. 1998.
6. Gluckman PD, Hanson MA. Developmental origins of disease paradigm: a mechanistic and evolutionary perspective. Trends Endocrinol Metab 2004;15:83-187.
7. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008;359:61-73.
8. Thornburg KL, Shannon J, Thuillier P, Turke MS. In utero life and epigenetic predisposition for disease. Adv Genet 2010;71: 57-78.
9. Mazzuca MQ, Wlodek ME, Dragomir NM, et al. Uteroplacental insufficiency programs regional vascular dysfunction and alters arterial stiffness in female offspring. J Physiol 2010;588: 1997-2010.
10. Brosens I, Puttemans P, Benagiano G Endometriosis: a life cycle approach? Am J Obstet Gynecol [Epub ahead of print].
11. Fara GM, Del Corno G Pregnancy outcome in the Seveso area after TCDD contamination. Prog Clin Biol Res 1985;163B:279-85.
12. Shilotri NP, Raval MY, Hinduja IN. Gynaecological and obstetrical survey of Bhopal women following exposure to methyl isocyanate. J Postgrad Med 1986;32:203-5.
13. Hoffmann W. Fallout from the Chernobyl nuclear disaster and congenital malformations in Europe. Arch Environ Health 2001;56: 478-84.
14. Crinnion WJ. Maternal levels of xenobiotics that affect fetal development and childhood health. Altern Med Rev 2009;14: 212-22.
15. Crain DA, Janssen SJ, Edwards TM, et al. Female reproductive disorders: the roles of endocrine disrupting compounds and developmental timing. Fertil Steril 2008;90:911-40.
16. Gilbert SF. Mechanisms for the environmental regulation of gene expression: ecological aspects of animal development. J Biosci 2005;30:65-74.
17. Guo S-W. Epigenetics of endometriosis. Mol Hum Reprod 2009;15: 587-607.
18. Diamanti-Kandarakis E, Bourguignon J-P, Giudice LC, et al. Endocrine-disrupting chemicals: An Endocrine Society scientific statement. Endocr Rev 2009;30:293-342.
19. Umezawa M, Sakata C, Tanaka N, et al. Pathological study for the effects of in utero and postnatal exposure to diesel exhaust on a rat endometriosis model. J Toxicol Sci 2001;36:493-8.
20. Krugner-Higby L, Rosenstein A, Handschke L, et al. Inguinal hernias, endometriosis, and other adverse outcomes in rhesus monkeys following lead exposure. Neurotoxicol Teratol 2003;25: 561-70.
21. Kumar S. Is environmental exposure associated with reproductive health impairments? J Turkish German Gynecol Ass 2008;9:60-9.
22. U.S. Food and Drug Administration. Bisphenol A (BPA): Use in Food Contact Application. Available from: http://www.fda.gov/newsevents/publichealthfocus/ ucm064437.htm [last accessed 25 Oct 2012].
23. Newbold RR, Jefferson WN, Padilla-Banks E. Long-term adverse effects of neonatal exposure to bisphenol A on the murine female reproductive tract. Reprod Toxicol 2007;24:253-8.
24. Signorile PG, Spugnini EP, Citro G, et al. Endocrine disruptors in utero cause ovarian damages linked to endometriosis. Front Biosci (Elite edition) 2012;4:1724-30.
25. Tsutsumi O. Assessment of human contamination of estrogenic endocrine-disrupting chemicals and their risk for human reproduction. J Steroid Biochem Mol Biol 2005;93:325-30.
26. World Health Organisation. Dioxins and their effects on human health. Fact sheet N°225 May 2010. Available from: http://www.who.int/mediacentre/ factsheets/fs225/en/[last accessed 25 Oct 2012].
27. Rier SE, Martin DC, Bowman RE, et al. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2, 3, 7, 8-tetrachlorodibenzo-p- dioxin. Fundam Appl Toxicol 1993; 21:433-41.
28. Eskenazi B, Kimmel G Workshop on perinatal exposure to dioxin-like compounds. II. Reproductive effects. Environ Health Perspect 1995;103:143-5.
29. Guo S-W. The link between exposure to dioxin and endometriosis: a critical reappraisal of primate data. Gynecol Obstet Invest 2004; 57:157-73.
30. Bruner-Tran KL, Osteen KG. Dioxin-like PCBs and endometriosis. Syst Biol Reprod Med 2010;56:132-46.
31. Mayani A, Barel S, Soback S, Almagor M. Dioxin concentrations in women with endometriosis. Hum Reprod 1997;12:373-5.
32. Pauwels A, Schepens PJC, D'Hooghe T, et al. The risk of endometriosis and exposure to dioxins and polychlorinated biphenyls: a case-control study of infertile women. Hum Reprod 2001;16:2050-5.
33. Torf G, Hagmar L, Giwercman A, Bonde JP. Epidemiological evidence on reproductive effects of persistent organochlorines in humans. Reprod Toxicol 2004;19:5-26.
34. Simsa P, Mihalyi A, Schoeters G, et al. Increased exposure to dioxin-like compounds is associated with endometriosis in a case-control study in women. Reprod BioMed Online 2010;20:681-8.
35. Nayyar T, Bruner-Tran KL, Piestrzeniewicz-Ulanska D, Osteen KG. Developmental exposure of mice to TCDD elicits a similar uterine phenotype in adult animals as observed in women with endometriosis. Reprod Toxicol 2007;23:326-36.
36. Igarashi TM, Bruner-Tran KL, Yeaman GR, et al. Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2, 3, 7, 8-tetrachlorodibenzo-p- dioxin. Fertil Steril 2005; 84:67-74.
37. Bruner-Tran KL, Yeaman GR, Crispens MA, et al. Dioxin may promote inflammation-related development of endometriosis. Fertil Steril 2008;89:1287-98.
38. Rier SE. Environmental immune disruption: a comorbidity factor for reproduction? Fertil Steril 2008;89:e103-8.
39. Herington JL, Bruner-Tran KL, Lucas JA, Osteen KG. Immune interactions in endometriosis. Exp Rev Clin Immunol 2011;7: 611-26.
40. Foster WG. Endocrine toxicants including 2, 3, 7, 8-terachlorodi-benzo-p- dioxin (TCDD) and dioxin-like chemicals and endometri-osis: is there a link? J Toxicol Environ Health-Part B: Crit Rev 2008;11:177-87.
41. Yang Q, Khoury MJ, James LM, et al. The return of thalidomide: are birth defects surveillance systems ready? Am J Med Genet 1997;73:251-8.
42. Tuffs A. Thalidomide: the true story? BMJ 2007;334:933.
43. Huss KS. Maternal diethylstilbestrol a time bomb for child? J Am Med Ass 1971;218:1564-5.
44. Smith EK, White MC, Weir HK, et al. Higher incidence of clear cell adenocarcinoma of the cervix and vagina among women born between 1947 and 1971 in the United States. Cancer Causes Control 2012;23:207-11.
45. Haney AF, Hammond MG. Infertility in women exposed to diethylstilbestrol in utero. J Reprod Med 1983;28:851-6.
46. Miller LC, Stillman RJ. Diethylstilbestrol exposure in utero and endometriosis in infertile females. Fertil Steril 1984;41:369-72.
47. Berger MJ, Alper MM. Intractable primary infertility in women exposed to diethylstilbestrol in utero. J Reprod Med 1986;31: 231-5.
48. Missmer SA, Hankinson SE, Spiegelman D, et al. In utero exposures and the incidence of endometriosis. Fertil Steril 2004; 82:1501-8.
49. Hoover RN, Hyer M, Pfeiffer RM, et al. Adverse health outcomes in women exposed in utero to diethylstilbestrol. N Engl J Med 2011; 365:1304-14.
50. Matalliotakis IM, Cakmak H, Koukoura OG, et al. Endometriosis after in utero exposure to DES: Presentation of case reports from the Yale patient series. Internat J Fertil Women Med 2008;53: 125-9.
51. Bellelis P, Podgaec S, Abrao MS. Environmental factors and endometriosis. Rev Assoc Med Brasil 2011;57:448-52.
52. Newbold R. Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens. Environ Health Perspect 1995;103:83-7.
53. Missmer SA, Chavarro JE, Malspeis S, et al. A prospective study of dietary fat consumption and endometriosis risk. Hum Reprod 2010; 25:1528-35.
54. Trabert B, Peters U, De Roos AJ, et al. Diet and risk of endometriosis in a population-based case-control study. Brit J Nutrition 2011;105:459-67.
55. Vassiliadis S, Athanassakis I. A "conditionally essential" nutrient, L-carnitine, as a primary suspect in endometriosis. Fertil Steril 2011;95:2759-60.
56. Hediger ML, Hartnett HJ, Louis GM. Association of endometriosis with body size and figure. Fertil Steril 2005;84:1366-74.
57. Vitonis AF, Baer HJ, Hankinson SE, et al. A prospective study of body size during childhood and early adulthood and the incidence of endometriosis. Hum Reprod 2010;25:1325-34.
58. Buck Louis GM, Hediger ML, Pena JB. Intrauterine exposures and risk of endometriosis. Hum Reprod 2007;22:3232-6.
59. Somigliana E, Vigano P, Abbiati A, et al. Perinatal environment and endometriosis. Gynecol Obstet Invest 2011;72:135-40.
60. Wolff EF, Sun LP, Hediger ML, et al. In utero exposures and endometriosis: the Endometriosis, Natural history, Disease, Outcome (ENDO) Study. Fertil Steril 2013;99:790-5.